{"id":"NCT00256750","sponsor":"Bristol-Myers Squibb","briefTitle":"Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)","officialTitle":"Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-03","primaryCompletion":"2008-06","completion":"2015-04","firstPosted":"2005-11-22","resultsPosted":"2016-08-19","lastUpdate":"2016-08-19"},"enrollment":738,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Kidney Transplantation","Chronic Kidney Failure"],"interventions":[{"type":"DRUG","name":"Cyclosporine (CsA)","otherNames":[]},{"type":"DRUG","name":"Belatacept LI (less intensive)","otherNames":[]},{"type":"DRUG","name":"Belatacept MI (more intensive)","otherNames":[]}],"arms":[{"label":"Cyclosporine (CsA)","type":"ACTIVE_COMPARATOR"},{"label":"Belatacept LI (less intensive)","type":"EXPERIMENTAL"},{"label":"Belatacept MI (more intensive)","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to learn if Belatacept can provide protection from organ rejection following kidney transplantation while avoiding some of the toxic effects of standard immunosuppressive medications such as kidney damage. Effects on kidney function and patient survival as well as drug safety will also be studied.","primaryOutcome":{"measure":"Percent of Participants Surviving With a Functioning Graft by Month 12","timeFrame":"Day 1 to Month 12","effectByArm":[{"arm":"Cyclosporine","deltaMin":92.8,"sd":null},{"arm":"Belatacept LI","deltaMin":96.5,"sd":null},{"arm":"Belatacept MI","deltaMin":95.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG002","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":105,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Canada","Czechia","France","Germany","Hungary","India","Israel","Italy","Mexico","Poland","South Africa","Spain","Sweden","Switzerland","Turkey (TÃ¼rkiye)"]},"refs":{"pmids":["26816011","24831918","21992533"],"seeAlso":["http://www.bms.com/studyconnect/Pages/home.aspx","http://www.bms.com/clinical_trials/Pages/Investigator_Inquiry_form.aspx"]},"adverseEventsSummary":{"seriousAny":{"events":167,"n":215},"commonTop":["Diarrhoea","Anaemia","Hypertension","Urinary tract infection","Oedema peripheral"]}}